Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
17,410,719
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
287,497
-
Shares change
-
-121,730
-
Total reported value, excl. options
-
$304,746
-
Value change
-
-$34,328
-
Number of buys
-
5
-
Number of sells
-
5
-
Price
-
$1.06
Institutional Holders of ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) as of Q1 2025
As of 31 Mar 2025 ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) had 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 287,497 shares of stock of the company.
Largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, VANGUARD GROUP INC, UBS Group AG, NORTHERN TRUST CORP, STATE STREET CORP, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., and BANK OF AMERICA CORP /DE/.
This table shows 13 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.